The construction of recombinant β-galactosidase adenovirus and its expression in transduced rat aortic smooth muscle cells
Junfeng Wang
Abstract
Junfeng Wang
Abstract
Objective To construct a replication-defective recombinant adenovirus expressing β-galactosidase for providing a control vector in future study of gene therapy for restenosis, and of safety, feasibility, and efficiency of gene transfer mediated by adenovirus. Methods The shuttle vector pAd-β-gal was constructed by recombinant DNA technology and characterized by endonuclease digestion and agarose gel electrophoresis. Ad-β-gal was generated by homologous recombination and characterized by staining the transfected 293 cells with X-gal. The virus titer was determined by measuring the absorbance at 260 nm.Rat aortic vascular smooth muscle cells (VSMCs) were cultured by explant methods and characterized by specific smooth muscle α-actin immunohistochemical staining. VSMCs were transfected with Ad-β-gal at 100 moi and stained with X-gal to observe the expression of β-galactosidase. Results (1)pAd-β-gal shuttle vector and Ad-β-gal were constructed successfully;(2)The transfected 293 cells and VSMCs were stained blue with X-gal;(3)The virus titer is 9×10 11 pfu/ml;(4)The efficiency of gene transfer in VSMCs at 100 moi was nearly 100%. Conclusions (1)The recombinant adenovirus expressing β-galactosidase, Ad-β-gal, was constructed, successfully;(2) This investigation provides an excellent control vector for future study of gene therapy in restenosis;(3)Ad-β-gal is a useful tool in the research of safety, feasibility and the efficiency of gene transfer mediated by adenovirus.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To construct a replication-defective recombinant adenovirus expressing β-galactosidase for providing a control vector in future study of gene therapy for restenosis, and of safety, feasibility, and efficiency of gene transfer mediated by adenovirus. Methods The shuttle vector pAd-β-gal was constructed by recombinant DNA technology and characterized by endonuclease digestion and agarose gel electrophoresis. Ad-β-gal was generated by homologous recombination and characterized by staining the transfected 293 cells with X-gal. The virus titer was determined by measuring the absorbance at 260 nm.Rat aortic vascular smooth muscle cells (VSMCs) were cultured by explant methods and characterized by specific smooth muscle α-actin immunohistochemical staining. VSMCs were transfected with Ad-β-gal at 100 moi and stained with X-gal to observe the expression of β-galactosidase. Results (1)pAd-β-gal shuttle vector and Ad-β-gal were constructed successfully;(2)The transfected 293 cells and VSMCs were stained blue with X-gal;(3)The virus titer is 9×10 11 pfu/ml;(4)The efficiency of gene transfer in VSMCs at 100 moi was nearly 100%. Conclusions (1)The recombinant adenovirus expressing β-galactosidase, Ad-β-gal, was constructed, successfully;(2) This investigation provides an excellent control vector for future study of gene therapy in restenosis;(3)Ad-β-gal is a useful tool in the research of safety, feasibility and the efficiency of gene transfer mediated by adenovirus.
Key concepts: Transfection, Molecular biology, Recombinant DNA, Viral vector, Genetic enhancement, Shuttle vector, Biology, Titer